Patent · US Active

Use of intramolecularly, covalently cross-linked proteins as binding partners in immunoassays

US7547533B2 · kind B2 · utility

0Cited by

4References

11Claims

0Family size

Assignee

Roche Diagnostics Operations, Inc. · US

Inventors

Barbara Upmeier · Iffeldorf, DE
Dittmar Schlieper · Weilheim, DE
Frederic Donie · Penzberg, DE

Key dates

Filing date	Jan 3, 2008
Grant date	Jun 16, 2009
Priority date	—
Expiry date	Jan 3, 2028

Classification

Technology area (CPC G)Physics
CPC primaryG01N33/56988
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The invention concerns the use of intramolecularly, covalently cross-linked proteins and covalently cross-linked reverse transcriptase from HIV as immunological binding partners in immunoassays. It also concerns immunological test procedures for detecting an analyte in a sample in which intramolecularly, covalently cross-linked proteins are used as binding partners, and it further concerns intramolecularly, covalently cross-linked reverse transcriptase from HIV and a method for producing this reverse transcriptase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.